Humana Q1 Earnings Beats Expectations, Raises FY22 Profit Guidance

  • Humana Inc HUM has posted Q1 adjusted sales of $24.08 billion, beating the consensus of $23.51 billion.
  • The benefits expense ratio increased from 86.4% to 85.9%, and the operating cost ratio increased from 12% to 9.7%. 
  • Humana posted an adjusted EPS of $8.04, beating the consensus of $6.78 and $6.38 posted a year ago.
  • Related: Humana to Offload Substantial Stake In Kindred At Home Hospice & Personal Care Divisions.
  • Guidance: Humana expects FY22 GAAP EPS of at least approximately $24.50, up from prior guidance of $24, versus the consensus of $24.17.
  • The updated guidance includes a $1.00 embedded COVID headwind and the estimated dilutive impact related to the pending divestiture of Humana's 60% stake in Kindred at Home's Hospice and Personal Care divisions.
  • The Company reaffirms FY 2022 expected individual Medicare Advantage membership growth range of approximately 150,000 to 200,000.
  • Price Action: HUM shares are up 3.18% at $444.17 during the market session on the last check Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLarge CapNewsGuidanceHealth CareGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!